166 related articles for article (PubMed ID: 15916433)
21. Retrospective docking study of PDE4B ligands and an analysis of the behavior of selected scoring functions.
Mpamhanga CP; Chen B; McLay IM; Ormsby DL; Lindvall MK
J Chem Inf Model; 2005; 45(4):1061-74. PubMed ID: 16045302
[TBL] [Abstract][Full Text] [Related]
22. Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 2: metabolism-directed optimization studies towards orally bioavailable derivatives.
Vergne F; Bernardelli P; Lorthiois E; Pham N; Proust E; Oliveira C; Mafroud AK; Ducrot P; Wrigglesworth R; Berlioz-Seux F; Coleon F; Chevalier E; Moreau F; Idrissi M; Tertre A; Descours A; Berna P; Li M
Bioorg Med Chem Lett; 2004 Sep; 14(18):4615-21. PubMed ID: 15324875
[TBL] [Abstract][Full Text] [Related]
23. CoMFA and CoMSIA 3D-quantitative structure-activity relationship model on benzodiazepine derivatives, inhibitors of phosphodiesterase IV.
Ducrot P; Andrianjara CR; Wrigglesworth R
J Comput Aided Mol Des; 2001 Sep; 15(9):767-85. PubMed ID: 11776290
[TBL] [Abstract][Full Text] [Related]
24. Recent trends in library design: 'rational design' revisited.
Schnur DM
Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
[TBL] [Abstract][Full Text] [Related]
25. Virtual screening and scaffold hopping based on GRID molecular interaction fields.
Ahlström MM; Ridderström M; Luthman K; Zamora I
J Chem Inf Model; 2005; 45(5):1313-23. PubMed ID: 16180908
[TBL] [Abstract][Full Text] [Related]
26. 8-Substituted analogues of 3-(3-cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl-adenine: highly potent and selective PDE4 inhibitors.
Whitehead JW; Lee GP; Gharagozloo P; Hofer P; Gehrig A; Wintergerst P; Smyth D; McCoull W; Hachicha M; Patel A; Kyle DJ
J Med Chem; 2005 Feb; 48(4):1237-43. PubMed ID: 15715490
[TBL] [Abstract][Full Text] [Related]
27. Phosphodiesterase 9: insights from protein structure and role in therapeutics.
Singh N; Patra S
Life Sci; 2014 Jun; 106(1-2):1-11. PubMed ID: 24746902
[TBL] [Abstract][Full Text] [Related]
28. Survey of the diversity space coverage of reported combinatorial libraries.
Fitzgerald SH; Sabat M; Geysen HM
J Comb Chem; 2007; 9(4):724-34. PubMed ID: 17567080
[TBL] [Abstract][Full Text] [Related]
29. Structure-based discovery of highly selective phosphodiesterase-9A inhibitors and implications for inhibitor design.
Meng F; Hou J; Shao YX; Wu PY; Huang M; Zhu X; Cai Y; Li Z; Xu J; Liu P; Luo HB; Wan Y; Ke H
J Med Chem; 2012 Oct; 55(19):8549-58. PubMed ID: 22985069
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor.
Macdonald D; Mastracchio A; Perrier H; Dubé D; Gallant M; Lacombe P; Deschênes D; Roy B; Scheigetz J; Bateman K; Li C; Trimble LA; Day S; Chauret N; Nicoll-Griffith DA; Silva JM; Huang Z; Laliberté F; Liu S; Ethier D; Pon D; Muise E; Boulet L; Chan CC; Styhler A; Charleson S; Mancini J; Masson P; Claveau D; Nicholson D; Turner M; Young RN; Girard Y
Bioorg Med Chem Lett; 2005 Dec; 15(23):5241-6. PubMed ID: 16168647
[TBL] [Abstract][Full Text] [Related]
31. Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors.
Edmondson SD; Mastracchio A; He J; Chung CC; Forrest MJ; Hofsess S; MacIntyre E; Metzger J; O'Connor N; Patel K; Tong X; Tota MR; Van der Ploeg LH; Varnerin JP; Fisher MH; Wyvratt MJ; Weber AE; Parmee ER
Bioorg Med Chem Lett; 2003 Nov; 13(22):3983-7. PubMed ID: 14592490
[TBL] [Abstract][Full Text] [Related]
32. Similarity searching and scaffold hopping in synthetically accessible combinatorial chemistry spaces.
Boehm M; Wu TY; Claussen H; Lemmen C
J Med Chem; 2008 Apr; 51(8):2468-80. PubMed ID: 18380426
[TBL] [Abstract][Full Text] [Related]
33. Increased building block access through collaboration.
Helal CJ; Bartolozzi A; Goble SD; Mani NS; Guzman-Perez A; Ohri AK; Shi ZC; Subramanyam C
Drug Discov Today; 2018 Aug; 23(8):1458-1462. PubMed ID: 29571837
[No Abstract] [Full Text] [Related]
34. Bioactive compounds from Leycesteria formosa.
Lobstein A; Yepes Y; Um BH; Weniger B; Lugnier C; Anton R
Pharmazie; 2002 Jun; 57(6):431-2. PubMed ID: 12116886
[No Abstract] [Full Text] [Related]
35. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition.
Kaheinen P; Pollesello P; Hertelendi Z; Borbély A; Szilágyi S; Nissinen E; Haikala H; Papp Z
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):74-8. PubMed ID: 16433895
[TBL] [Abstract][Full Text] [Related]
36. Strategy for discovering chemical inhibitors of human cyclophilin a: focused library design, virtual screening, chemical synthesis and bioassay.
Li J; Zhang J; Chen J; Luo X; Zhu W; Shen J; Liu H; Shen X; Jiang H
J Comb Chem; 2006; 8(3):326-37. PubMed ID: 16677001
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of flavonoid analogues as scaffolds for natural product-based combinatorial libraries.
Yao N; Song A; Wang X; Dixon S; Lam KS
J Comb Chem; 2007; 9(4):668-76. PubMed ID: 17487987
[TBL] [Abstract][Full Text] [Related]
38. Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
Faisy C; Risse PA; Naline E; Guerot E; Fagon JY; Devillier P; Advenier C
Life Sci; 2006 Oct; 79(20):1929-35. PubMed ID: 16820175
[TBL] [Abstract][Full Text] [Related]
39. Design of focused and restrained subsets from extremely large virtual libraries.
Jamois EA; Lin CT; Waldman M
J Mol Graph Model; 2003 Nov; 22(2):141-9. PubMed ID: 12932785
[TBL] [Abstract][Full Text] [Related]
40. 2,1,3-Benzothiadiazine derivatives: synthesis and screening versus PDE4 enzyme.
Tait A; Luppi A; Avallone R; Baraldi M
Farmaco; 2005 Aug; 60(8):653-63. PubMed ID: 15963514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
